ENFAMIL w. IRON OTC
Generic Name and Formulations:
Protein (nonfat milk, reduced minerals whey), carbohydrate (lactose), fat (palm olein, soy, coconut, and high oleic sunflower oils), mono- and diglycerides, soy lecithin, carrageenan (liquid forms only), iron 1.8mg/100Cal, taurine, vitamins, minerals, nucleotides.
Mead Johnson Nutrition
Indications for ENFAMIL w. IRON:
Feeding for full term healthy infants or for sick infants without special nutritional needs. Supplement to breast feeding.
Prepared as directed provides 20Cal/oz.
Infant formula with iron.
Enfamil Lipil (low iron): Pwd—12.9oz; Ready-to-use—32oz; Enfamil Lipil w. iron: Conc—13oz; Ready-to-use—8oz, 32oz; Pwd—12.9oz, 25.7oz; Nursette—3oz, 6oz; Enfamil w. iron: Conc—13oz cans; Ready-to-use—32oz cans
Pwd—14.3oz, 28.5oz; Nursettes—3oz; Enfamil AR Lipil: Pwd—12.9oz; Nursettes—3oz; Ready-to-use—32oz; Enfamil Gentlease Lipil: Pwd—12oz, 24oz
Clinical Pain Advisor Articles
- History of Migraine May Be Associated With Higher Risk for Cochlear Disorders
- Radiofrequency Denervation Efficacious in Treating Thoracic Zygapophyseal Joint Pain
- Symptom Severity, Sensory Sensitivity May Indicate Pain Centralization in Chronic Overlapping Pain Conditions
- Stat Consult: Chronic Low Back Pain
- Opioid Misuse May Help Predict Alcohol Dependence Treatment Outcomes
- Consensus Guidelines for the Use of Intravenous Ketamine for Chronic Pain
- Pain Societies Issue Guidelines on Use of Ketamine for the Management of Acute Pain
- Labor Epidural Analgesia Linked to Reduced Likelihood of Successful Breastfeeding
- Novel Oral Treatment Safe, Effective for Migraine Headache Relief
- DFN-02 Nasal Spray Safe, Effective for Acute Treatment of Episodic Migraine
- Chinese Traditional Medicine Showed Effectiveness on Pain, Quality of Life in Advanced Cancer
- International Group Develops Best Practices for Drug Packaging
- New Rules May Constrain Docs' Ability to Treat Chronic Pain
- OnabotulinumtoxinA May Be Effective for Chronic Migraine With Medication Overuse
- FDA Outlines Plan for Increasing Nonprescription Drug Availability